Stock ILMN ILLUMINA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Illumina, Inc.

Equities

ILMN

US4523271090

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
113.7 USD -0.88% Intraday chart for Illumina, Inc. +9.03% -18.34%
Jun. 06 TD Cowen Adjusts Price Target on Illumina to $122 From $140 MT
Jun. 05 Nephron Research Upgrades Illumina to Hold, Price Target at $100 MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost
PR
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares
PR
Illumina appoints Everett Cunningham Chief Commercial Officer
PR
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO
AQ
Illumina releases 2023 Corporate Social Responsibility Report
PR
Anna Richo joins Illumina's Board of Directors
PR
Illumina To Webcast Upcoming Investor Conference
PR
Devyser Diagnostics AB publishes quarterly report for the period January to March 2024
AQ
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL
PR
Illumina to Webcast Upcoming Investor Conference
AQ
Illumina To Webcast Upcoming Investor Conference
PR
Illumina : First Quarter 2024 Prepared Remarks
PU
Illumina: Q1 Earnings Snapshot
AQ
Illumina : 2024 Assurance Statement
PU
Illumina's planned divestment of GRAIL approved by the European Commission
AQ
Illumina's planned divestment of GRAIL approved by the European Commission
PR
Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer
PR
Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024
PR
GRAIL Presents New Data on Galleri and Its Methylation Platform at the Annual American Association for Cancer Research Meeting
AQ
Devyser Diagnostics AB publishes year-end report for January to December 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ILMN Stock
  4. News Illumina, Inc.
  5. Press Releases